{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:42:17Z","timestamp":1789245737083,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Preserving fertility is crucial when managing male patients with spondyloarthritis (SpA) and\/or psoriasis (PsO), especially in young men. Chronic inflammation, hormonal dysregulation and immunosuppressive therapies can negatively impact male fertility. Over the past decades, positive data have emerged regarding the reproductive safety of various therapies in men. Ixekizumab (IXE), a high-affinity monoclonal antibody targeting IL-17A, has shown a safe profile for male fertility in small studies. This pilot study assesses the impact of IXE treatment on sperm parameters in SpA and\/or PsO patients in a real-world setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Consecutive adult male SpA and\/or PsO patients eligible for or undergoing IXE treatment were prospectively enrolled. Demographic data, disease characteristics, laboratory assessments, comorbidities and previous treatments were recorded. Sperm analysis was conducted after a minimum of 6\u2009months of IXE treatment, and also before treatment inititation in a subgroup of patients. Parallel sperm evaluations were performed in a control group of healthy donors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ten patients were enrolled: eight with SpA and two with PsO. After 6\u2009months of IXE treatment, all patients had normal sperm parameters. One SpA and PsO patient with baseline oligozoospermia showed normal parameters at follow-up and achieved a successful pregnancy post-treatment. Compared with controls, IXE-treated patients had lower sperm concentrations but higher vitality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In our limited-size pilot study on SpA and PsO patients, IXE exposure did not impair male fertility. Sperm parameters remained within normal ranges after a minimum of 6\u2009months of treatment. Early IXE treatment may preserve or potentially reverse fertility impairment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae609","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:00:56Z","timestamp":1730818856000},"page":"4316-4319","source":"Crossref","is-referenced-by-count":1,"title":["Male fertility is preserved following ixekizumab treatment\u2014a real-life pilot study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3239-5628","authenticated-orcid":false,"given":"Mihaela C","family":"Micu","sequence":"first","affiliation":[{"name":"Rheumatology Division, Rehabilitation Clinical Hospital , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7650-2582","authenticated-orcid":false,"given":"Nicola","family":"Farina","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana P","family":"Decean","sequence":"additional","affiliation":[{"name":"Dermatology Department, Clinical Military Emergency Hospital \u201cConstantin Papilian\u201d Cluj-Napoca, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Micu","sequence":"additional","affiliation":[{"name":"\u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"Surd","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Department, Gynecology I Clinic Cluj- Napoca, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinela","family":"G\u00eerlovanu","sequence":"additional","affiliation":[{"name":"VenusMed Fertility Clinic , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Andone-Rotaru","sequence":"additional","affiliation":[{"name":"VenusMed Fertility Clinic , Cluj-Napoca,","place":["Romania"]},{"name":"Interdisciplinary Research Institute in Bio-Nano-Sciences, Babes-Bolyai University , Cluj-Napoca,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]},{"name":"Vita Salute San Raffaele University , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025070205013790300_keae609-B1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semarthrit.2018.01.006","article-title":"Paternal exposure to antirheumatic drugs-What physicians should know: review of the literature","volume":"48","author":"Micu","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025070205013790300_keae609-B2","doi-asserted-by":"crossref","first-page":"155834","DOI":"10.1016\/j.cyto.2022.155834","article-title":"Interferon \u03b3, IL-17, and IL-1\u03b2 impair sperm motility and viability and induce sperm apoptosis","volume":"152","author":"Paira","year":"2022","journal-title":"Cytokine"},{"key":"2025070205013790300_keae609-B3","first-page":"333","article-title":"Matrix metalloproteinase-9 is elevated and related to interleukin-17 and psychological stress in male infertility: a cross-sectional study","volume":"19","author":"Mary","year":"2021","journal-title":"Int J Reprod Biomed"},{"key":"2025070205013790300_keae609-B4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/17512433.2021.1925536","article-title":"Biologics and small molecules in the management of psoriatic arthritis: reproduction related issues in female and male patients","volume":"14","author":"Fischer-Betz","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025070205013790300_keae609-B5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.37897\/RJR.2018.2.3","article-title":"Fertility in men diagnosed with ankylosing spondylitis- a population based study","volume":"27","author":"Micu","year":"2018","journal-title":"Romanian J Rheumatol"},{"key":"2025070205013790300_keae609-B6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2009.127423","article-title":"Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis","volume":"69","author":"Villiger","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu007","article-title":"TNF-alpha inhibitors do not impair sperm quality in males with ankylosing spondylitis after short term or long-term treatment","volume":"53","author":"Micu","year":"2014","journal-title":"Rheumatology"},{"key":"2025070205013790300_keae609-B8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3899\/jrheum.180588","article-title":"Pregnancy outcomes in couples with males exposed to longterm anti-tumor necrosis factor-\u03b1 inhibitor therapies: a prospective study","volume":"46","author":"Micu","year":"2019","journal-title":"J Rheumatol"},{"key":"2025070205013790300_keae609-B9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ard-2023-224017","article-title":"Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies","volume":"82","author":"Reinisch","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B10","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1093\/rheumatology\/keaa189","article-title":"Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials","volume":"59","author":"Genovese","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025070205013790300_keae609-B11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2022.0655","article-title":"Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: the IXORA-PEDS Randomized Clinical Trial","volume":"158","author":"Paller","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2025070205013790300_keae609-B12"},{"key":"2025070205013790300_keae609-B13","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1080\/09546634.2021.1976375","article-title":"Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab","volume":"33","author":"Egeberg","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2025070205013790300_keae609-B14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/annrheumdis-2024-eular.3287","article-title":"POS1388 Semen analysis of patients with psoriatic arthritis, axial spondyloarthritis and healthy controls","volume":"83","author":"Meridor","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025070205013790300_keae609-B18","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris\u2014Part 1: treatment and monitoring recommendations","volume":"34","author":"Nast","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025070205013790300_keae609-B19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2025070205013790300_keae609-B20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2021-220709","article-title":"Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility)","volume":"80","author":"Perez-Garcia","year":"2021","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae609\/60629244\/keae609.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4316\/60629244\/keae609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4316\/60629244\/keae609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:01:48Z","timestamp":1751446908000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/7\/4316\/7876293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae609","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2024,11,5]]}}}